08h00 – 08h45 | STRAUSS | Highlights Session
Immunotherapy in Cancer
I. Melero
Early Drug Development
J.H. Schellens
GU Prostate and Non Prostate
R. Cathomas
09h15 – 10h45 | HALL A3 | Patient Advocacy Session: Clinical Trials - What Really Matters to Patients
Chair: M. Piccart
Co-Chair: B. Ryll
Panel Discussion
A. Eggermont
J. Reis-Filho
L.L. Siu
S. Erdem
13h00 – 14h30 | SPOTLIGHT B1 | Workshop: Making the Right Oncology Career Choices for You
Coordinator: E. Martinelli
Speaker: F. Cardoso (Portugal)
15h15 – 16h15 | LEHAR 3 | Special Session: Evaluating Clinical Benefit of Cancer Drugs across Tumours
Chair: E.G. de Vries
Clinical benefit scale: The European proposal
M. Piccart
Clinical benefit scale: The challenge of fairness
U. Dafni
Clinical benefit scale: The EMA opinion
F. Pignatti
The effect of CBS on patient care: The patient’s perspective
S. Erdem
Discussion
16h45 – 18h45 | HALL A5 | ESMO Society Session
Chairs: Rolf Stahel and Fortunato Ciardello
17h00 – 18h30 | STOLZ 1 | Scientific Symposium: Making Survivor Care Evidence Based for the Growing Number of Survivors: Patients at the Forefront of Their Own Survivorship Care
Chair: S. Diler
Co-Chair: J. Gietema
How late effects in testicular cancer guide follow-up
H.S. Haugnes
Exploiting dormant information on long-term follow-up outcome of EORTC Lymphoma trials: The EORTC survivorship initiative
L. Moser (Portugal)
How to involve the primary care physician in survivor care for growing
E. Grunfeld
Patients in control of navigating their own survivor care plan
J. Gietema
